Tag Archives: life sciences
Formation Bio Raised $600 Million for a Debut Fund to Acquire and Develop Clinical-Stage Drug Programs:
HedgeCo.Net — Formation Bio, an AI-native pharmaceutical company, announced on October 28 the Formation Bio Drug Development Accelerator Fund, a debut vehicle with $600 million in … Continue reading
EQT Agreed to Take QIAGEN Private at €46.50 a Share, Valuing It at About €10.8 Billion:
HedgeCo.Net — EQT has agreed to take QIAGEN private through a recommended, all-cash voluntary public takeover offer of €46.50 per share, a transaction the molecular testing company… Continue reading